Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cosmos HealthCOSM +11.24%24 Net Cash per Share is $-0.84 as of Mar. 2026. GuruFocus rates COSM with a GF Score™ of 24/100 and a GF Value™ of $0.35 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 5 Medical Distribution companies, Cosmos Health ranks worse than 19999980% on this metric.
The historical rank and industry rank for Cosmos Health's Net Cash per Share or its related term are showing as below:
COSM's Price-to-Net-Cash is not ranked *
in the Medical Distribution industry.
Industry Median: 3.7 * Ranked among companies with meaningful Price-to-Net-Cash only.
Cosmos Health (NAS:COSM) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
Cosmos Health Net Cash per Share Related Terms
Cosmos Health Net Cash per Share Historical Data
* Premium members only.
The historical data trend for Cosmos Health's Net Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSM vs HKPD, MEDS, SNYR: Net Cash per Share Comparison
For the Medical Distribution subindustry, Cosmos Health's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cosmos Health Price-to-Net-Cash vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cosmos Health's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where Cosmos Health's Price-to-Net-Cash falls into.
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
Cosmos Health's Net Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cosmos Health (COSM) has a Net Cash per Share of $-0.84 as of Mar. 2026. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Cosmos Health and its competitors. According to the industry distribution chart, Cosmos Health ranks #999999 out of 5 companies in the Medical Distribution industry.
Is Cosmos Health's Net Cash per Share too high?
Cosmos Health's current Net Cash per Share is $-0.84. Based on the distribution chart, Cosmos Health ranks #999999 out of 5 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Cosmos Health has a GF Score™ of 24/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cosmos Health's Net Cash per Share compare to HKPD and MEDS?
According to the Medical Distribution industry distribution chart, Cosmos Health ranks #999999 out of 5 companies for Net Cash per Share. This places Cosmos Health in the lower half of its industry. The industry median Net Cash per Share is 3.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for a Medical Distribution company?
The median Net Cash per Share among Medical Distribution companies is 3.70, based on 5 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Cosmos Health and its competitors. For the Medical Distribution industry, the median Net Cash per Share is 3.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cosmos Health's current Net Cash per Share is $-0.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmos Health stock overvalued right now?
Based on GuruFocus' analysis, Cosmos Health (COSM) is currently considered Possible Value Trap. The stock's GF Value™ is $0.35, compared to a current price of $0.24 — trading 32.9% below its estimated fair value. The current Net Cash per Share is $-0.84. Cosmos Health's overall GF Score™ is 24/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For Cosmos Health (COSM), the current Net Cash per Share is $-0.84 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cosmos Health (COSM) Overvalued in 2026?
Based on GuruFocus' analysis, Cosmos Health stock appears to be undervalued.
The current stock price of $0.24 is trading 32.9% below its estimated GF Value™ of $0.35.
GuruFocus considers Cosmos Health to be Possible Value Trap.
Key valuation signals for COSM:
Net Cash per Share: $-0.84
GF Value™: $0.35 vs. price of $0.24 (32.9% below fair value)
No single metric tells the full story. See the COSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
24GF Score
Get the complete analysis for COSM
Net Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COSM has been successfully added to your 
